ロード中...
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma
BACKGROUND: Neoadjuvant therapy followed by esophagectomy has been recognized as an effective treatment for locally advanced esophageal cancer, though still has a dismal prognosis. Antibodies against programmed death 1 (PD-1) protein improve survival in patients with advanced or metastatic esophagea...
保存先:
| 出版年: | J Gastrointest Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7944149/ https://ncbi.nlm.nih.gov/pubmed/33708420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-599 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|